Reactive oxygen species and nitric oxide effect on the steroid hormone binding with serum albumin

Journal of Pharmaceutical and Biomedical Analysis

Volumn 62, Issue , 2012, Pages 129-134

  Aljhni, R ^a   Ibrahim, F ^a   Guillaume, Y C ^a,b   Andre, C ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Albumin; Column liquid chromatography; Nitric oxide; Reactive oxygen species; Steroid hormone

Indexed keywords

ESTRADIOL; HYDROGEN PEROXIDE; HYDROXYL RADICAL; NITRIC OXIDE; PRASTERONE; PROGESTERONE; REACTIVE OXYGEN METABOLITE; SERUM ALBUMIN; SILICON DIOXIDE; TESTOSTERONE;

ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD; CHROMATOGRAPHY; ENTHALPY; ENTROPY; HYDROGEN BOND; OXIDATION; PRIORITY JOURNAL; STEROID BINDING;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HORMONES; NITRIC OXIDE; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; SERUM ALBUMIN; STEROIDS; THERMODYNAMICS;

EID: 84857139738     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2011.12.037     Document Type: Article

References (27)

1. Harman D. Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11:298-300.
2. Sudlow G., Birkett D.J., Wade D.N. Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol. 1976, 12:1052-1061.
3. He X.M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature 1992, 358:209-215.
4. Saeed T., Salahuddin A. Preparation and characterization of fragments from the N-terminal end of bovine serum albumin under native conditions. Biochem. J. 1993, 296:347-350.
5. Sułkowska A. Interaction of drugs with bovine and human serum albumin. J. Mol. Struct. 2002, 614:227-232.
6. André C., Xicluna A., Robert J.-F., Thomassin M., Guillaume Y.-C. Reanalysis of the testosterone displacement from its HSA binding site by DHEA using competitive Langmuir isotherm. Talanta 2005, 65:814-818.
7. Hage D.S., Austin J. High-performance affinity chromatography and immobilized serum albumin as probes for drug and hormone protein binding. J. Chromatogr. B 2000, 739:39-54.
8. Loun B., Hage D.S. Characterization of thyroxine albumin binding using highperformance affinity chromatography: I. Interactions at the warfarin and indole sites of albumin. J. Chromatogr. B 1992, 579:225-235.
9. Guillaume Y.C, Millet J., Nicod L., Truong-Thanh T., Guinchard C., Xicluna A., Thomassin M. Solute complexation degree with human serum albumin: biochromatographic approach. J. Chromatogr. B 2002, 768:121-127.
10. Nisula B.C., Dunn J.F. Measurement of the testosterone binding parameters for both testosterone-estradiol binding globulin and albumin in individual serum samples. Steroids 1979, 34:771-791.
11. Liang P., Adhyaru B., Pearson W.L., Williams K.R. The binding constant of estradiol to bovine serum albumin. An upper-level experiment utilizing tritium-labeled estradiol and liquid scintillation counting. J. Chem. Educ. 2006, 83:296-298.
12. Zhong D., Douhal A., Zewail A.H. Femtosecond studies of protein-ligand hydrophobic binding and dynamics: human serum albumin. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:14056-14061.
13. Valko K., Nunhuck S., Bevan C., Abraham M.H., Reynolds D.P. Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity. J. Pharm. Sci. 2003, 92:2236-2248.
14. Melander W., Campbell D.E., Horváth C. Enthalpy-entropy compensation in reversed-phase chromatography. J. Chromatogr. A 1978, 158:215-225.
15. Krug R.R. Detection of the compensation effect (6 Rule). Ind. Eng. Chem. Fundam. 1980, 19:50-59.
16. Cole L.A., Dorsey J.G., Dill K.A. Temperature dependence of retention in reversed-phase liquid chromatography. 2. Mobile-phase considerations. Anal. Chem. 1992, 64:1324-1327.
17. Oettl K., Stauber R.E. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br. J. Pharmacol. 2007, 151:580-590.
18. Anraku M., Yamasaki K., Maruyama T., Kragh-Hansen U., Otagiri M. Effect of oxidative stress on the structure and function of human serum albumin. Pharm. Res. 2001, 18:632-639.
19. Rondeau P., Singh N.R., Caillens H., Tallet F., Bourdon E. Oxidative stresses induced by glycoxidized human or bovine serum albumin on human monocytes. Free Radic. Biol. Med. 2008, 45:799-812.
20. André C., Guillaume Y.C. Zinc-human serum albumin association: testimony of two binding sites. Talanta 2004, 63:503-508.
21. Zhihua Z., Goldstein B.D., Witz G. Iron-stimulated ring-opening of benzene in a mouse liver microsomal system: mechanistic studies and formation of a new metabolite. Biochem. Pharmacol. 1995, 50:1607-1617.
22. Wang R.M., Mao J.J., Song J.F., Huo C.X., He Y.F. Antioxidant activity of bovine serum albumin binding amino acid Schiff-bases metal complexes. Chin. Chem. Lett. 2007, 18:1416-1418.
23. Soltys B.J., Hsia J.C. Steroid modulation of human serum albumin binding properties. J. Biol. Chem. 1978, 253:4266-4269.
24. Smit I.W.M., Ravishankara A.R. Role of hydrogen-bonded intermediates in the bimolecular reactions of the hydroxyl radical. J. Phys. Chem. A 2002, 106:4798-4807.
25. Kashiba-Iwatsuki M., Miyamoto M., Inoue M. Effect of nitric oxide on the ligand-binding activity of albumin. Arch. Biochem. Biophys. 1997, 345:237-242.
26. Ewing J.F., Young D.V., Janero D.R., Garvey D.S., Grinnell T.A. Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners. J. Pharmacol. Exp. Ther. 1997, 283:947-954.
27. Burczynski F.J., Wang G.-Q., Hnatowich M. Effect of nitric oxide on albumin palimate binding. Biochem. Pharmacol. 1995, 49:91-96.